NLRP3 inflammasome activity is negatively controlled by miR-223

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4175-4181

  Bauernfeind, Franz ^a   Rieger, Anna ^a   Schildberg, Frank A ^a   Knolle, Percy A ^a   Schmid Burgk, Jonathan L ^a   Hornung, Veit ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; MICRORNA 223;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; CARRIER PROTEINS; CELL LINE, TRANSFORMED; DOWN-REGULATION; HEK293 CELLS; HUMANS; INFLAMMASOMES; L CELLS (CELL LINE); MICE; MICE, INBRED C57BL; MICRORNAS; MYELOID CELLS; T-LYMPHOCYTE SUBSETS;

EID: 84867304098     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201516     Document Type: Article

References (29)

1. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821-832.
2. Dinarello, C. A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27: 519-550.
3. Bauernfeind, F., A. Ablasser, E. Bartok, S. Kim, J. Schmid-Burgk, T. Cavlar, and V. Hornung. 2011. Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 68: 765-783.
4. O'Connor, W., Jr., J. A. Harton, X. Zhu, M. W. Linhoff, and J. P. Ting. 2003. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J. Immunol. 171: 6329-6333.
5. Bauernfeind, F., E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V. Hornung. 2011. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187: 613-617.
6. Bauernfeind, F. G., G. Horvath, A. Stutz, E. S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B. G. Monks, K. A. Fitzgerald, et al. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183: 787-791.
7. Hornung, V., and E. Latz. 2010. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 40: 620-623.
8. Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
9. Baek, D., J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
10. Guo, H., N. T. Ingolia, J. S. Weissman, and D. P. Bartel. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
11. O'Neill, L. A., F. J. Sheedy, and C. E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11: 163-175.
12. Lodish, H. F., B. Zhou, G. Liu, and C. Z. Chen. 2008. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8: 120-130.
13. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9: 847-856.
14. Gentner, B., G. Schira, A. Giustacchini, M. Amendola, B. D. Brown, M. Ponzoni, and L. Naldini. 2009. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6: 63-66.
15. Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R. Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
16. Franchi, L., T. Eigenbrod, and G. Núñez. 2009. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 183: 792-796.
17. Sutterwala, F. S., Y. Ogura, M. Szczepanik, M. Lara-Tejero, G. S. Lichtenberger, E. P. Grant, J. Bertin, A. J. Coyle, J. E. Galán, P. W. Askenase, and R. A. Flavell. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.
18. Fazi, F., A. Rosa, A. Fatica, V. Gelmetti, M. L. De Marchis, C. Nervi, and I. Bozzoni. 2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: 819-831.
19. Fukao, T., Y. Fukuda, K. Kiga, J. Sharif, K. Hino, Y. Enomoto, A. Kawamura, K. Nakamura, T. Takeuchi, and M. Tanabe. 2007. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129: 617-631.
20. Johnnidis, J. B., M. H. Harris, R. T. Wheeler, S. Stehling-Sun, M. H. Lam, O. Kirak, T. R. Brummelkamp, M. D. Fleming, and F. D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by micro-RNA-223. Nature 451: 1125-1129.
21. Masters, S. L., A. Simon, I. Aksentijevich, and D. L. Kastner. 2009. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (&z.ast;). Annu. Rev. Immunol. 27: 621-668.
22. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
23. Khameneh, H. J., S. A. Isa, L. Min, F. W. Nih, and C. Ruedl. 2011. GM-CSF signalling boosts dramatically IL-1 production. PLoS ONE 6: e23025.
24. Mankan, A. K., T. Dau, D. Jenne, and V. Hornung. 2012. The NLRP3/ASC/Caspase-1 axis regulates IL-1b processing in neutrophils. Eur. J. Immunol. 42: 710-715.
25. Zhuang, G., C. Meng, X. Guo, P. S. Cheruku, L. Shi, H. Xu, H. Li, G. Wang, A. R. Evans, S. Safe, et al. 2012. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125: 2892-2903.
26. Martinon, F., V. Pétrilli, A.Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
27. Duewell, P., H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nuñez, M. Schnurr, et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
28. Masters, S. L., A. Dunne, S. L. Subramanian, R. L. Hull, G. M. Tannahill, F. A. Sharp, C. Becker, L. Franchi, E. Yoshihara, Z. Chen, et al. 2010. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nat. Immunol. 11: 897-904.
29. Halle, A., V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. Fitzgerald, E. Latz, K. J. Moore, and D. T. Golenbock. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9: 857-865.